Morgan Stanley’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $46.1M | Sell |
|
|||||
2025
Q1 | $40.1M | Sell |
|
|||||
2024
Q4 | $43.8M | Sell |
|
|||||
2024
Q3 | $39.4M | Sell |
|
|||||
2024
Q2 | $58.4M | Buy |
|
|||||
2024
Q1 | $22.7M | Sell |
|
|||||
2023
Q4 | $133M | Buy |
|
|||||
2023
Q3 | $63.9M | Buy |
|
|||||
2023
Q2 | $61.8M | Buy |
|
|||||
2023
Q1 | $40M | Sell |
|
|||||
2022
Q4 | $142M | Buy |
|
|||||
2022
Q3 | $269M | Sell |
|
|||||
2022
Q2 | $208M | Sell |
|
|||||
2022
Q1 | $365M | Sell |
|
|||||
2021
Q4 | $582M | Buy |
|
|||||
2021
Q3 | $695M | Buy |
|
|||||
2021
Q2 | $527M | Sell |
|
|||||
2021
Q1 | $676M | Sell |
|
|||||
2020
Q4 | $637M | Sell |
|
|||||
2020
Q3 | $705M | Buy |
|
|||||
2020
Q2 | $485M | Buy |
|
|||||
2020
Q1 | $349M | Sell |
|
|||||
2019
Q4 | $401M | Sell |
|
|||||
2019
Q3 | $346M | Buy |
|
|||||
2019
Q2 | $416M | Buy |
|
|||||
2019
Q1 | $147M | Sell |
|
|||||
2018
Q4 | $79.5M | Buy |
|